Medifocus, Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that a review article summarizing clinical studies of the Company's Microfocus APA 1000 Breast Cancer Thermotherapy System was published online December 22, 2009 in the journal Annals of Surgical Oncology. The article "Focused Microw

A 21-gene test that predicts whether early stage breast cancer patients will benefit from chemotherapy is having a big impact on treatment decisions by patients and doctors alike. The test caused doctors to change their treatment recommendations in 31.5 percent of cases, while 27 percent of patient

Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-lin

Most breast cancer surgeons' practices do not follow standards associated with the best quality of care, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. These standards include consulting with other specialists and providing resources and educatio

Scientists at the University of Michigan Comprehensive Cancer Center have uncovered an important link between inflammation and breast cancer stem cells that suggests a new way to target cells that are resistant to current treatments. The researchers identified a receptor, CXCR1, on the cancer stem

Not only is acupuncture as effective as drug therapy at reducing hot flashes in breast cancer patients, it has the added benefit of potentially increasing a woman's sex drive and improving her sense of well-being, according to a Henry Ford Hospital study. Study results show that acupuncture, when c